SPW
OTLK icon

Signet Private Wealth’s Outlook Therapeutics OTLK Stock Holding History

Signet Private Wealth’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
+17,555
New +$10.9K 0.02% 127

Other funds holding OTLK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
CKAIS
Christensen King & Associates Investment Services Richland, Washington $252M AUM 20.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Signet Private Wealth's OTLK Position: Q2 2026 in Review

Signet Private Wealth opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 17,555 shares worth $27.9K. The stake represents 0.02% of the portfolio and ranks #127 among its holdings.

26 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Signet Private Wealth held 17,555 shares of Outlook Therapeutics worth $27.9K as of Q2 2026.
  • Outlook Therapeutics was a new Signet Private Wealth position in Q2 2026.
  • Outlook Therapeutics made up 0.02% of Signet Private Wealth's portfolio in Q2 2026, its #127 holding.
  • 26 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Signet Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.